South San Francisco
California, United States of America
The Early Clinical Development (ECD) group in Oncology at Genentech is seeking a talented physician scientist to join our Cancer Immunotherapy development team to translate our preclinical discoveries into the next generation of cancer immunotherapies for patients. The ECD Oncology Group at Genentech conducts first-in-human Phase I and Phase II studies with novel agents against a variety of immunotherapy targets with a strong focus on mechanism-based biomarkers, seeking the next generation of therapies that will benefit patients.
This Assistant/Associate Medical Director will be leading a development team that is studying a novel cancer immunotherapy target as a single-agent and in combination with other immunotherapy agents in multiple solid tumors and hematological malignancies. This Assistant/Associate Medical Director will lead the design, execution, monitoring, analysis, and reporting of innovative Phase I/II clinical studies, with an initial focus on cancer immunology and novel immune-modulating agents, including studies of rational scientific combinations. Eventual opportunities to lead the development of other novel targets within our extensive oncology portfolio are also anticipated. This physician scientist will provide leadership for internal cross-functional teams in the clinical development of a novel immunotherapy target and will be the primary point of contact for communicating with external global oncology leaders, clinical investigators, and scientists. This physician scientist will directly work with research scientists in the Cancer Immunology Research group and the Oncology Biomarker Development group at Genentech, and may also work with the Genentech Partnering group on in-licensing opportunities in cancer immunotherapy.
This Assistant/Associate Medical Director will be designing and conducting efficient, interpretable clinical studies and programs that address high priority exciting questions in oncology and cancer immunotherapy that are supported by Genentech’s outstanding commitment to fundamental cancer research, its scientific leadership in cancer immunology, and its vibrant patient-oriented culture.
Candidates must have an M.D. or M.D./Ph.D. with board certification or eligibility in Oncology or Hematology/Oncology.
Candidates should have an excellent scientific record with experience in laboratory-based cancer research and/or oncology clinical trials, either within an academic institution or the pharmaceutical industry, and research and/or clinical experience in Cancer Immunotherapy is preferred.
Candidates should have the desire and ability to effectively participate within multidisciplinary teams and have the ability to interact with external experts and investigators.
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
At Genentech, we share salary ranges with applicants during the recruiting process, if requested. Third party salary estimates may not be accurate or up-to-date.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech